209 related articles for article (PubMed ID: 6753513)
1. 5-Hydroxytryptamine in the pathogenesis of affective disorders.
Coppen A; Wood K
Adv Biochem Psychopharmacol; 1982; 34():249-58. PubMed ID: 6753513
[No Abstract] [Full Text] [Related]
2. Therapy of affective disorders.
Alexander B; Cook B
Prim Care; 1990 Sep; 17(3):565-88. PubMed ID: 2236337
[TBL] [Abstract][Full Text] [Related]
3. The treatment of affective disorders in the elderly.
Georgotas A; Cooper T; Kim M; Hapworth W
Psychopharmacol Bull; 1983; 19(2):226-37. PubMed ID: 6346375
[No Abstract] [Full Text] [Related]
4. Current concepts in clinical therapeutics: major affective disorders, Part 1.
Bryant SG; Brown CS
Clin Pharm; 1986 Apr; 5(4):304-18. PubMed ID: 3519059
[TBL] [Abstract][Full Text] [Related]
5. Primary affective disorders.
Donlon PT
J Fam Pract; 1979 Oct; 9(4):689-99. PubMed ID: 39109
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Meltzer HY
Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
[No Abstract] [Full Text] [Related]
7. Affective disorders in the aged.
Lehmann HE
Psychiatr Clin North Am; 1982 Apr; 5(1):27-44. PubMed ID: 6124957
[No Abstract] [Full Text] [Related]
8. Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
Uytdenhoef P; Linkowski P; Mendlewicz J
Neuropsychobiology; 1982; 8(2):60-72. PubMed ID: 6175919
[No Abstract] [Full Text] [Related]
9. Underuse of evidence-based pharmacotherapies for affective disorders.
Dwight-Johnson M; Lagomasino IT; Simpson GM
Psychiatr Serv; 2003 Aug; 54(8):1076-8. PubMed ID: 12883130
[No Abstract] [Full Text] [Related]
10. [Dynamics of platelet serotonin levels in affective disorders].
Karas' SI; Kornetov NA; Makarova EV; Sherina OL
Biull Eksp Biol Med; 1994 Mar; 117(3):240-2. PubMed ID: 8204839
[No Abstract] [Full Text] [Related]
11. Circadian rhythm mechanisms in affective illness and in antidepressant drug action.
Wehr TA; Wirz-Justice A
Pharmacopsychiatria; 1982 Jan; 15(1):31-9. PubMed ID: 7038719
[No Abstract] [Full Text] [Related]
12. Importance of neuroplasticity changes in mood disorder.
Tobe EH
J Am Osteopath Assoc; 2011 Apr; 111(4):298-300. PubMed ID: 21562301
[No Abstract] [Full Text] [Related]
13. [Treatment of refractory primary depression].
van Praag HM
Ned Tijdschr Geneeskd; 1997 Jul; 141(28):1375-9. PubMed ID: 9380197
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptomatology and drug response.
Bech P
Commun Psychopharmacol; 1978; 2(5):409-18. PubMed ID: 216525
[No Abstract] [Full Text] [Related]
15. [The role of serotonin in affective disorders (author's transl)].
Lingjaerde O
Encephale; 1979; 5(5 Suppl):499-506. PubMed ID: 95007
[No Abstract] [Full Text] [Related]
16. [Tricyclics, MAOI and electroshock therapy in the treatment of depressive syndromes].
Carolei A; Frontoni M
Clin Ter; 1981 Jul; 98(1):75-86. PubMed ID: 7018824
[No Abstract] [Full Text] [Related]
17. [Treatment of depressive disorders].
Saiz Ruiz J; Ibáñez Cuadrado A
Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
[No Abstract] [Full Text] [Related]
18. [Discussion of reports on new orientations in the treatment of affective disturbances].
Encephale; 1979; 5(5 Suppl):737-42. PubMed ID: 548282
[No Abstract] [Full Text] [Related]
19. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Gross R; Grunhaus L
South Med J; 1995 Feb; 88(2):249-50. PubMed ID: 7839179
[No Abstract] [Full Text] [Related]
20. Psychoactive drugs and the frail elderly patient.
Kvale JN
Am Fam Physician; 1984 Oct; 30(4):133-40. PubMed ID: 6149680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
